Spray-Dried Biologics Market 2026 growing toward $3.2 billion by 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Spray-Dried Biologics Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The spray-dried biologics market has seen swift growth in its size over recent years. It is anticipated to expand from $1.86 billion in 2025 to $2.08 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.7%. The expansion observed in the historical period is attributable to advancements in biologics formulation science, an increase in biologic drug approvals, the necessity for improved drug stability, the growth of vaccine manufacturing capacity, and the adoption of advanced pharmaceutical processing technologies.

The spray-dried biologics market is anticipated to experience substantial growth over the next few years, reaching a valuation of $3.2 billion by 2030 with a compound annual growth rate (CAGR) of 11.4%. This projected increase is largely due to factors such as the escalating demand for non-injectable biologics, greater investments in dry powder delivery systems, the expansion of worldwide vaccine production, an intensified focus on minimizing cold-chain dependency, and progress in spray-drying equipment design. Prominent trends for this period include the increasing adoption of spray-drying methods for biologic stabilization, a rise in the need for inhalable and oral biologic formulations, the broadening of continuous spray-drying processes, the expanding application of dry powder biologics in vaccine development, and an enhanced focus on prolonging product shelf-life.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30401&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Spray-Dried Biologics Market?

The rising need for biopharmaceuticals is anticipated to drive expansion within the spray-dried biologics market in the foreseeable future. Biopharmaceuticals represent therapeutic items originating from biological origins, such as living cells, proteins, and various biomolecules. The increasing global prevalence of chronic and intricate health conditions is fueling the heightened demand for biopharmaceuticals, generating an urgent requirement for treatments characterized by greater specificity, enhanced effectiveness, and reduced systemic adverse reactions. The spray-dried biologics industry observes heightened interest as the swift growth of biopharmaceuticals compels enterprises to adopt adaptable formulation techniques that boost stability, prolong shelf life, and optimize delivery efficiency. For instance, in February 2025, the World Health Organization (WHO), an international public health body based in Switzerland, reported that its essential medicines list (EML) in 2023 featured 81 biologic therapies, making up over 15% of all essential medicines. Consequently, the rising need for biopharmaceuticals is a key factor driving the expansion of the spray-dried biologics market.

What Major Segment Divisions Exist Within The Spray-Dried Biologics Market?

The spray-dried biologics market covered in this report is segmented –

1) By Product Type: Monoclonal Antibodies, Vaccines, Enzymes, Hormones, Other Product Types

2) By Route Of Administration: Oral, Inhalation Or Pulmonary, Injectable, Topical

3) By End-User: Hospitals, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Monoclonal Antibodies: Chimeric Antibodies, Humanized Antibodies, Fully Human Antibodies, Bispecific Antibodies, Antibody Fragments

2) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Viral Vector Vaccines, Recombinant Protein Vaccines

3) By Enzymes: Therapeutic Enzymes, Digestive Enzymes, Metabolic Enzymes, Recombinant Enzymes, Replacement Enzymes

4) By Hormones: Peptide Hormones, Protein Hormones, Steroid Hormones, Recombinant Hormones, Growth Hormones

5) By Other Product Types: Blood Factors, Cytokines, Fusion Proteins, Nucleic Acid Therapeutics, Cell Culture Media Proteins

How Are Trends Shaping The Direction Of The Spray-Dried Biologics Market?

Leading companies within the spray-dried biologics market are concentrating on integrating technological advancements, such as drum dosing technology, to improve dose accuracy, powder handling efficiency, and reliable large-scale capsule filling. This advanced powder-filling method employs a rotating drum with precision-engineered dosing cavities and vacuum-assisted transfer to accurately meter and deposit dry powders into capsules, thereby enabling consistent low-dose filling, enhanced flow management for spray-dried powders, and high-throughput scalability. For example, in February 2024, Catalent Inc., a US-based contract development and manufacturing organization (CDMO), upgraded its inhalation manufacturing facility in the US, incorporating potent capsule-filling capabilities powered by drum-based dosing systems and in-line advanced mass verification. This enhanced platform supports the precise filling of engineered and spray-dried powders, offering real-time dose validation and controlled low-humidity processing. The upgrade consequently boosts manufacturing efficiency, product consistency, and readiness for commercial-scale production of spray-dried biologic dry-powder inhalation therapies.

Which Companies Are Leading Innovation In The Spray-Dried Biologics Market?

Major companies operating in the spray-dried biologics market are Thermo Fisher Scientific Inc., Evonik Industries AG, Lonza Group AG, GEA Group, Fareva Group, Almac Group Limited, Seqens Group, Fabbrica Italiana Sintetici S.p.A., CordenPharma International, Hovione FarmaCiencia SA, Veranova Inc., Pace Analytical Services LLC, Olon S.p.A., Nova Laboratories Ltd, Leukocare AG, Micro Sphere SA, Seran Bioscience LLC, CritiTech Particle Engineering Solutions LLC, Xedev BV, BÜCHI Labortechnik AG.

Read the full spray-dried biologics market report here:

https://www.thebusinessresearchcompany.com/report/global-spray-dried-biologics-market-report

What Are The Leading Geographic Regions In The Spray-Dried Biologics Market?

North America was the largest region in the spray-dried biologics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spray-dried biologics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Spray-Dried Biologics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30401&type=smp

Browse Through More Reports Similar to the Global Spray-Dried Biologics Market 2026, By The Business Research Company

Biologics Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

Spray Drying Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/spray-drying-equipment-global-market-report

Agricultural Biologics Market Report 2026

https://www.thebusinessresearchcompany.com/report/agricultural-biologics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795